80 related articles for article (PubMed ID: 3105870)
1. Establishment of a human B-cell tumor in athymic mice.
Leonard JE; Johnson DE; Felsen RB; Tanney LE; Royston I; Dillman RO
Cancer Res; 1987 Jun; 47(11):2899-902. PubMed ID: 3105870
[TBL] [Abstract][Full Text] [Related]
2. Penetration and binding of antibodies in experimental human solid tumors grown in mice.
Ong GL; Mattes MJ
Cancer Res; 1989 Aug; 49(15):4264-73. PubMed ID: 2743313
[TBL] [Abstract][Full Text] [Related]
3. Establishment of ascitic tumor of human pre-B acute lymphoblastic leukemia in nonconditioned nude mice.
Luo Y; Hara H; Haruta Y; Seon BK
Cancer Res; 1989 Feb; 49(3):706-10. PubMed ID: 2783384
[TBL] [Abstract][Full Text] [Related]
4. Malignant lymphoma antigen expressed in nude mouse tumor cells derived from carcinogen-transformed Bloom's syndrome B-lymphoblastoid cell lines.
Shiraishi Y; Moriki T; Hara H; Araki K; Kozuru M; Sandberg AA
Cancer Res; 1990 May; 50(10):3106-12. PubMed ID: 2185881
[TBL] [Abstract][Full Text] [Related]
5. Anti-B4-blocked ricin immunotoxin shows therapeutic efficacy in four different SCID mouse tumor models.
Shah SA; Halloran PM; Ferris CA; Levine BA; Bourret LA; Goldmacher VS; Blättler WA
Cancer Res; 1993 Mar; 53(6):1360-7. PubMed ID: 7680284
[TBL] [Abstract][Full Text] [Related]
6. Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains.
Klein G; Ehlin-Henriksson B; Schlossman SF
J Immunol; 1983 Apr; 130(4):1985-9. PubMed ID: 6300235
[TBL] [Abstract][Full Text] [Related]
7. Establishment of new SCID and nude mouse models of human B leukemia/lymphoma and effective therapy of the tumors with immunotoxin and monoclonal antibody: marked difference between the SCID and nude mouse models in the antitumor efficacy of monoclonal antibody.
Kawata A; Yoshida M; Okazaki M; Yokota S; Barcos M; Seon BK
Cancer Res; 1994 May; 54(10):2688-94. PubMed ID: 8168098
[TBL] [Abstract][Full Text] [Related]
8. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002
[TBL] [Abstract][Full Text] [Related]
9. Tumorigenicity in nude mice of a human hepatoma cell line containing hepatitis B virus DNA.
Shouval D; Reid LM; Chakraborty PR; Ruiz-Opazo N; Morecki R; Gerber MA; Thung SN; Shafritz DA
Cancer Res; 1981 Apr; 41(4):1342-50. PubMed ID: 6260336
[TBL] [Abstract][Full Text] [Related]
10. Radioimmunotherapy of nude mice bearing a human interleukin 2 receptor alpha-expressing lymphoma utilizing the alpha-emitting radionuclide-conjugated monoclonal antibody 212Bi-anti-Tac.
Hartmann F; Horak EM; Garmestani K; Wu C; Brechbiel MW; Kozak RW; Tso J; Kosteiny SA; Gansow OA; Nelson DL
Cancer Res; 1994 Aug; 54(16):4362-70. PubMed ID: 8044783
[TBL] [Abstract][Full Text] [Related]
11. Distribution of a new B-cell-associated surface antigen (BL7) detected by a monoclonal antibody in human leukemic disorders.
Al-Katib A; Wang CY; Koziner B
Cancer Res; 1985 Jul; 45(7):3058-63. PubMed ID: 3924396
[TBL] [Abstract][Full Text] [Related]
12. Loss of the tumorigenic phenotype with in vitro, but not in vivo, passaging of a novel series of human bronchial epithelial cell lines: possible role of an alpha 5/beta 1-integrin-fibronectin interaction.
Schiller JH; Bittner G
Cancer Res; 1995 Dec; 55(24):6215-21. PubMed ID: 8521416
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunotherapy of human B-cell chronic lymphocytic leukemia in nude mice.
Zhu Z; Ghose T; Hoskin D; Lee CL; Fernandez LA; Lee SH; Mammen M
Cancer Res; 1994 Oct; 54(19):5111-7. PubMed ID: 7923127
[TBL] [Abstract][Full Text] [Related]
14. Enhanced antitumor effects of CD20 over CD19 monoclonal antibodies in a nude mouse xenograft model.
Hooijberg E; van den Berk PC; Sein JJ; Wijdenes J; Hart AA; de Boer RW; Melief CJ; Hekman A
Cancer Res; 1995 Feb; 55(4):840-6. PubMed ID: 7531616
[TBL] [Abstract][Full Text] [Related]
15. Identification of a monoclonal antibody, TV-1, directed against the basement membrane of tumor vessels, and its use to enhance the delivery of macromolecules to tumors after conjugation with interleukin 2.
Epstein AL; Khawli LA; Hornick JL; Taylor CR
Cancer Res; 1995 Jun; 55(12):2673-80. PubMed ID: 7780984
[TBL] [Abstract][Full Text] [Related]
16. Development and distribution of a human B cell subpopulation identified by the HB-4 monoclonal antibody.
Tedder TF; Clement LT; Cooper MD
J Immunol; 1985 Mar; 134(3):1539-44. PubMed ID: 3918104
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a newly established malignant meningioma cell line of the human brain: IOMM-Lee.
Lee WH
Neurosurgery; 1990 Sep; 27(3):389-95; discussion 396. PubMed ID: 2234331
[TBL] [Abstract][Full Text] [Related]
18. Novel intrapulmonary model for orthotopic propagation of human lung cancers in athymic nude mice.
McLemore TL; Liu MC; Blacker PC; Gregg M; Alley MC; Abbott BJ; Shoemaker RH; Bohlman ME; Litterst CC; Hubbard WC
Cancer Res; 1987 Oct; 47(19):5132-40. PubMed ID: 3621199
[TBL] [Abstract][Full Text] [Related]
19. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
Rapp L; Fuji H
Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
[TBL] [Abstract][Full Text] [Related]
20. B-cell differentiation antigen expressed on a human myeloma cell line (KMM-1).
Togawa A; Inoue N; Mannoji M; Namba M
Jpn J Clin Oncol; 1983 Sep; 13(3):511-5. PubMed ID: 6417374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
